MYLAN 351 (Haloperidol 0.5 mg)
Pill imprint MYLAN 351 has been identified as Haloperidol 0.5 mg.
Haloperidol is used in the treatment of dementia; psychosis; icu agitation; nausea/vomiting; mania (and more), and belongs to the drug class miscellaneous antipsychotic agents. Risk cannot be ruled out during pregnancy. Haloperidol 0.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- MYLAN 351
- Strength:
- 0.5 mg
- Color:
- Orange
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0351
- Inactive Ingredients:
- silicon dioxide
FD&C Yellow No. 6
magnesium stearate
microcrystalline cellulose
corn starch
sodium lauryl sulfate
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0733 | UDL Laboratories Inc |
| 68071-0494 | Nucare Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
More about haloperidol
Consumer resources
- Haloperidol
- Haloperidol decanoate
- Haloperidol solution
- Haloperidol tablets
- Haloperidol injection
- More (2) »
- Other brands: Haldol, Haldol Decanoate
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
